Tactile Systems Technology (TCMD) vs. Its Peers Financial Survey

Tactile Systems Technology (NASDAQ:TCMD) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its rivals? We will compare Tactile Systems Technology to related companies based on the strength of its profitability, analyst recommendations, institutional ownership, valuation, risk, dividends and earnings.

Profitability

This table compares Tactile Systems Technology and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	6.68%	10.73%	8.53%
Tactile Systems Technology Competitors	-276.78%	-149.08%	-21.73%

Analyst Ratings

This is a breakdown of current recommendations for Tactile Systems Technology and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0	2	4	0	2.67
Tactile Systems Technology Competitors	4270	10532	18290	828	2.46

Tactile Systems Technology currently has a consensus target price of $36.80, indicating a potential upside of 39.55%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 19.51%. Given Tactile Systems Technology’s stronger consensus rating and higher probable upside, analysts clearly believe Tactile Systems Technology is more favorable than its rivals.

Valuation & Earnings

This table compares Tactile Systems Technology and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Tactile Systems Technology	$329.52 million	$19.09 million	25.60
Tactile Systems Technology Competitors	$1.89 billion	$137.77 million	9.37

Tactile Systems Technology’s rivals have higher revenue and earnings than Tactile Systems Technology. Tactile Systems Technology is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Insider & Institutional Ownership

83.4% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

Tactile Systems Technology has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, Tactile Systems Technology’s rivals have a beta of 2.57, indicating that their average stock price is 157% more volatile than the S&P 500.

Summary

Tactile Systems Technology beats its rivals on 8 of the 13 factors compared.

About Tactile Systems Technology

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.